Prothena Corp Public PRTA
NASDAQ PRTA
$8.78 +0.06 (+0.69%)
At close: Sep 29, 2026 · 4:00 PM EDT

Prothena Corp Public (PRTA) Share-based Compensation (2012 - 2026)

Updated

Prothena Corp Public (PRTA) recorded Share-based Compensation of $7.88 million in Q2 2026, down 36.6% from $12.42 million a year earlier but up 13.9% from the prior quarter.

Analysis

Prothena Corp Public (PRTA) Share-based Compensation (2012 - 2026) Analysis & Trends

On a TTM basis, Prothena Corp Public's Share-based Compensation came in at $29.07 million as of Jun 30, 2026, down 35.3% year-over-year; for FY2025, it was $37.64 million, down 18.1% from FY2024.

  • Annual Share-based Compensation has a five-year compound annual growth rate of 11.3% (FY2020 to FY2025).
  • Across earlier years, Share-based Compensation came in at $45.96 million in FY2024 (+12.3%), $40.91 million in FY2023 (+30.6%), $31.32 million in FY2022 (+27.0%) and $24.66 million in FY2021 (+12.0%).
  • Quarterly Share-based Compensation has ranged from $6.06 million in Q3 2021 to $12.42 million in Q2 2025 over the past five years.
  • On a year-over-year basis, Share-based Compensation has declined for four consecutive quarters, with an average decline of 19.2% over the last eight quarters.
  • Peak year-over-year performance for Share-based Compensation in the last five years was growth of 49.2% in Q2 2022, against a decline of 36.8% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6.92 million (Q1 2026), $7.07 million (Q4 2025) and $7.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Prothena Corp Public 451.21 Mn -804.86 Mn - 7.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.88 Mn
Mar 31, 2026 6.92 Mn
Dec 31, 2025 7.07 Mn
Sep 30, 2025 7.20 Mn
Jun 30, 2025 12.42 Mn
Mar 31, 2025 10.95 Mn
Dec 31, 2024 10.52 Mn
Sep 30, 2024 11.02 Mn
Jun 30, 2024 12.04 Mn
Mar 31, 2024 12.38 Mn
Dec 31, 2023 11.08 Mn
Sep 30, 2023 10.94 Mn
Jun 30, 2023 10.10 Mn
Mar 31, 2023 8.79 Mn
Dec 31, 2022 7.43 Mn
Sep 30, 2022 7.97 Mn
Jun 30, 2022 8.26 Mn
Mar 31, 2022 7.66 Mn
Dec 31, 2021 6.89 Mn
Sep 30, 2021 6.06 Mn
API Access

Prothena Corp Public Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PRTA&period=max&api_key=YOUR_API_KEY